Alnylam Pharmaceuticals seeks an imaginative physician drug developer to provide clinical leadership in developing RNAi therapeutics across its expanding portfolio. The primary responsibility is to serve as the clinical lead physician for Alnylam’s Huntington’s program, while potentially supporting programs across therapeutic areas and stages of development as the pipeline evolves. The Executive Director will shape clinical development strategies, advance clinical trials with operational excellence, advise Research on the clinical feasibility of novel targets and proof-of-concept study design, and collaborate extensively with external experts. The role may also lead early-phase bench-to-bedside development programs. Working in a matrix organization with Regulatory, Biostatistics, Clinical Operations, Preclinical, Commercial, and QA teams, the Executive Director will ensure integrated development strategies and represent Alnylam Development at external meetings, including regulatory interactions and scientific meetings. This hybrid position requires weekly onsite presence and is primarily based at the Cambridge, Massachusetts headquarters or the Maidenhead, UK location. Relocation may be possible.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree